BG64125B1 - Полиморфни форми на дофетилид - Google Patents

Полиморфни форми на дофетилид Download PDF

Info

Publication number: BG64125B1
Authority: BG; Bulgaria
Prior art keywords: dofetilide; polymorphic; preparation; treatment; pharmaceutically acceptable
Prior art date: 1997-10-27

Application number

BG104373A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG104373A (en

Inventor

Ian C. Appleby

Trevor J. Newbury

Gary Nichols

Original Assignee

Pfizer Research And Development Company,N.V./S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-27

Filing date

2000-04-24

Publication date

2004-01-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG64125(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-24 Application filed by Pfizer Research And Development Company,N.V./S.A. filed Critical Pfizer Research And Development Company,N.V./S.A.

2000-12-29 Publication of BG104373A publication Critical patent/BG104373A/xx

2004-01-30 Publication of BG64125B1 publication Critical patent/BG64125B1/bg

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Cardiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

BG104373A 1997-10-27 2000-04-24 Полиморфни форми на дофетилид BG64125B1 (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9722662.5A GB9722662D0 (en)	1997-10-27	1997-10-27	Polymorphs
PCT/EP1998/006641 WO1999021829A1 (en)	1997-10-27	1998-10-09	Dofetilide polymorphs

Publications (2)

Publication Number	Publication Date
BG104373A BG104373A (en)	2000-12-29
BG64125B1 true BG64125B1 (bg)	2004-01-30

Family

ID=10821150

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104373A BG64125B1 (bg)	1997-10-27	2000-04-24	Полиморфни форми на дофетилид

Country Status (47)

Country	Link
US (1)	US6124363A (uk)
EP (1)	EP1027329B1 (uk)
JP (1)	JP3569495B2 (uk)
KR (1)	KR100366167B1 (uk)
CN (1)	CN1146537C (uk)
AP (1)	AP906A (uk)
AR (1)	AR015193A1 (uk)
AT (1)	ATE232199T1 (uk)
AU (1)	AU737668B2 (uk)
BG (1)	BG64125B1 (uk)
BR (1)	BR9813308A (uk)
CA (1)	CA2307121C (uk)
CO (1)	CO4970768A1 (uk)
DE (1)	DE69811256T2 (uk)
DK (1)	DK1027329T3 (uk)
DZ (1)	DZ2632A1 (uk)
EA (1)	EA002656B1 (uk)
ES (1)	ES2190620T3 (uk)
GB (1)	GB9722662D0 (uk)
GT (1)	GT199800165A (uk)
HK (1)	HK1033933A1 (uk)
HN (1)	HN1998000165A (uk)
HR (1)	HRP20000247B1 (uk)
HU (1)	HUP0004735A3 (uk)
ID (1)	ID24658A (uk)
IL (1)	IL135435A0 (uk)
IS (1)	IS2179B (uk)
MA (1)	MA24683A1 (uk)
MY (1)	MY123352A (uk)
NO (1)	NO325630B1 (uk)
NZ (1)	NZ503785A (uk)
OA (1)	OA11350A (uk)
PA (1)	PA8462001A1 (uk)
PE (1)	PE122199A1 (uk)
PL (1)	PL197379B1 (uk)
PT (1)	PT1027329E (uk)
SA (1)	SA98190834B1 (uk)
SI (1)	SI1027329T1 (uk)
SK (1)	SK5862000A3 (uk)
TN (1)	TNSN98193A1 (uk)
TR (1)	TR200001135T2 (uk)
TW (1)	TW449589B (uk)
UA (1)	UA67755C2 (uk)
UY (2)	UY25222A1 (uk)
WO (1)	WO1999021829A1 (uk)
YU (1)	YU24000A (uk)
ZA (1)	ZA989719B (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10019067C1 (de) *	2000-04-18	2001-10-04	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) *	2005-05-12	2008-02-05	Penta Biotech, Inc.	Peptide for assaying hERG channel binding
CZ307826B6 (cs)	2017-12-01	2019-05-29	Farmak, A.S.	Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11696902B2 (en)	2018-08-14	2023-07-11	AltaThera Pharmaceuticals, LLC	Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en)	2021-08-20	2023-03-21	AltaThera Pharmaceuticals LLC	Antiarrhythmic drug dosing methods, medical devices, and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EG18188A (en) *	1986-05-01	1992-09-30	Pfizer Ltd	Process for preparation anti-arhythmia agents
EP0898964A1 (en) *	1997-08-19	1999-03-03	Pfizer Inc.	Method for treating heart failure

1997
- 1997-10-27 GB GBGB9722662.5A patent/GB9722662D0/en not_active Ceased
1998
- 1998-09-10 UA UA2000042087A patent/UA67755C2/uk unknown
- 1998-10-08 TW TW087116747A patent/TW449589B/zh not_active IP Right Cessation
- 1998-10-09 JP JP2000517941A patent/JP3569495B2/ja not_active Expired - Fee Related
- 1998-10-09 CA CA002307121A patent/CA2307121C/en not_active Expired - Fee Related
- 1998-10-09 PT PT98965638T patent/PT1027329E/pt unknown
- 1998-10-09 KR KR10-2000-7004471A patent/KR100366167B1/ko not_active IP Right Cessation
- 1998-10-09 DK DK98965638T patent/DK1027329T3/da active
- 1998-10-09 IL IL13543598A patent/IL135435A0/xx not_active IP Right Cessation
- 1998-10-09 YU YU24000A patent/YU24000A/sh unknown
- 1998-10-09 AT AT98965638T patent/ATE232199T1/de not_active IP Right Cessation
- 1998-10-09 BR BR9813308-0A patent/BR9813308A/pt not_active Application Discontinuation
- 1998-10-09 TR TR2000/01135T patent/TR200001135T2/xx unknown
- 1998-10-09 HU HU0004735A patent/HUP0004735A3/hu unknown
- 1998-10-09 US US09/423,986 patent/US6124363A/en not_active Expired - Lifetime
- 1998-10-09 EA EA200000365A patent/EA002656B1/ru not_active IP Right Cessation
- 1998-10-09 NZ NZ503785A patent/NZ503785A/en unknown
- 1998-10-09 PL PL340805A patent/PL197379B1/pl unknown
- 1998-10-09 DE DE69811256T patent/DE69811256T2/de not_active Expired - Fee Related
- 1998-10-09 SI SI9830347T patent/SI1027329T1/xx unknown
- 1998-10-09 WO PCT/EP1998/006641 patent/WO1999021829A1/en not_active Application Discontinuation
- 1998-10-09 EP EP98965638A patent/EP1027329B1/en not_active Expired - Lifetime
- 1998-10-09 AU AU21512/99A patent/AU737668B2/en not_active Ceased
- 1998-10-09 SK SK586-2000A patent/SK5862000A3/sk unknown
- 1998-10-09 ES ES98965638T patent/ES2190620T3/es not_active Expired - Lifetime
- 1998-10-09 ID IDW20000767A patent/ID24658A/id unknown
- 1998-10-09 CN CNB988106213A patent/CN1146537C/zh not_active Expired - Fee Related
- 1998-10-22 PA PA19988462001A patent/PA8462001A1/es unknown
- 1998-10-22 AP APAP/P/1998/001371A patent/AP906A/en active
- 1998-10-23 AR ARP980105310A patent/AR015193A1/es unknown
- 1998-10-23 MY MYPI98004829A patent/MY123352A/en unknown
- 1998-10-23 PE PE1998001003A patent/PE122199A1/es not_active Application Discontinuation
- 1998-10-26 TN TNTNSN98193A patent/TNSN98193A1/fr unknown
- 1998-10-26 UY UY25222A patent/UY25222A1/es not_active IP Right Cessation
- 1998-10-26 ZA ZA9809719A patent/ZA989719B/xx unknown
- 1998-10-26 HN HN1998000165A patent/HN1998000165A/es unknown
- 1998-10-26 DZ DZ980242A patent/DZ2632A1/xx active
- 1998-10-26 MA MA25313A patent/MA24683A1/fr unknown
- 1998-10-27 GT GT199800165A patent/GT199800165A/es unknown
- 1998-10-27 CO CO98062885A patent/CO4970768A1/es unknown
- 1998-11-28 SA SA98190834A patent/SA98190834B1/ar unknown
1999
- 1999-01-08 UY UY25341A patent/UY25341A1/es not_active IP Right Cessation
2000
- 2000-03-31 IS IS5426A patent/IS2179B/is unknown
- 2000-04-20 OA OA1200000117A patent/OA11350A/en unknown
- 2000-04-24 BG BG104373A patent/BG64125B1/bg unknown
- 2000-04-27 NO NO20002191A patent/NO325630B1/no not_active IP Right Cessation
- 2000-04-27 HR HR970680A patent/HRP20000247B1/xx not_active IP Right Cessation
2001
- 2001-06-21 HK HK01104340A patent/HK1033933A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL340805A1 (en)	2001-02-26
KR100366167B1 (ko)	2003-01-09
ATE232199T1 (de)	2003-02-15
IS5426A (is)	2000-03-31
AP906A (en)	2000-11-30
CA2307121A1 (en)	1999-05-06
DE69811256T2 (de)	2003-09-18
HN1998000165A (es)	1999-02-09
EP1027329A1 (en)	2000-08-16
CA2307121C (en)	2006-12-05
ID24658A (id)	2000-07-27
YU24000A (sh)	2003-02-28
CN1146537C (zh)	2004-04-21
NO20002191L (no)	2000-04-27
US6124363A (en)	2000-09-26
HK1033933A1 (en)	2001-10-05
GT199800165A (es)	2000-04-19
KR20010031439A (ko)	2001-04-16
HUP0004735A3 (en)	2001-12-28
AU737668B2 (en)	2001-08-30
PA8462001A1 (es)	2000-05-24
IS2179B (is)	2006-12-15
DK1027329T3 (da)	2003-02-24
NO325630B1 (no)	2008-06-30
TNSN98193A1 (fr)	2005-03-15
TW449589B (en)	2001-08-11
TR200001135T2 (tr)	2000-09-21
NO20002191D0 (no)	2000-04-27
JP2001521023A (ja)	2001-11-06
GB9722662D0 (en)	1997-12-24
BG104373A (en)	2000-12-29
EA002656B1 (ru)	2002-08-29
JP3569495B2 (ja)	2004-09-22
PT1027329E (pt)	2003-04-30
UY25222A1 (es)	2000-12-29
CN1278246A (zh)	2000-12-27
SK5862000A3 (en)	2001-10-08
HUP0004735A2 (hu)	2001-10-28
SA98190834B1 (ar)	2006-08-21
BR9813308A (pt)	2000-08-22
MA24683A1 (fr)	1999-07-01
CO4970768A1 (es)	2000-11-07
HRP20000247A2 (en)	2000-10-31
IL135435A0 (en)	2001-05-20
OA11350A (en)	2003-12-17
AR015193A1 (es)	2001-04-18
UA67755C2 (uk)	2004-07-15
PE122199A1 (es)	1999-12-02
NZ503785A (en)	2004-11-26
MY123352A (en)	2006-05-31
SI1027329T1 (en)	2003-04-30
UY25341A1 (es)	1999-09-27
DZ2632A1 (fr)	2003-03-08
HRP20000247B1 (en)	2002-08-31
DE69811256D1 (de)	2003-03-13
WO1999021829A1 (en)	1999-05-06
EA200000365A1 (ru)	2000-12-25
EP1027329B1 (en)	2003-02-05
AP9801371A0 (en)	1998-12-31
AU2151299A (en)	1999-05-17
PL197379B1 (pl)	2008-03-31
ES2190620T3 (es)	2003-08-01
ZA989719B (en)	2000-04-26

Publication	Publication Date	Title
MXPA04012923A (es)	2005-03-31	Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
DE69332718T2 (de)	2003-12-04	Enantiomere von carbazolderivaten als 5-ht1-ähnliche agonisten
DE69112099T2 (de)	1996-02-08	Kristallinisches Salz von 4-(Di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indol.
KR20230021075A (ko)	2023-02-13	베타 아드레날린성 작용제의 형태 및 조성물
TW202106680A (zh)	2021-02-16	Glyt1抑制劑之固體形式
CN115461344B (zh)	2024-01-12	一种glp-1受体激动剂的晶型a及其制备方法
BG64125B1 (bg)	2004-01-30	Полиморфни форми на дофетилид
DE69815518T2 (de)	2004-04-22	S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide als 5-ht2 rezeptor antagonist
DE69324492T2 (de)	1999-09-02	1-azaadamantanderivate als 5-ht4 agonisten oder antagonisten und/oder 5-ht3 antagonisten
JP5312022B2 (ja)	2013-10-09	Ｎｍｄａ受容体チャネルブロック作用を示す化合物及びそれを用いた薬剤。
DE60205504T2 (de)	2006-06-08	Zitronensäure salz von einer therapeutischen verbindung und deren pharmazeutischen zusammensetzungen
JP4275407B2 (ja)	2009-06-10	新規な結晶構造を有するエリスロマイシン誘導体及びその製造方法
MXPA00004059A (en)	2002-03-26	Dofetilide polymorphs
CZ20001516A3 (cs)	2001-07-11	Polymorfy dofetilidu
EP0639568A1 (en)	1995-02-22	Piperidine compounds, their preparation and use in the treatment of neurodegenerative disorders
US12215085B2 (en)	2025-02-04	Cholinesterase inhibitor polymorph and application thereof
CA2607257A1 (en)	2006-11-16	Unsolvated and host-guest solvated crystalline forms of (2e,4s)-4-[(n-{[(2r)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-l-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and their pharmaceutical uses
PT1641797E (pt)	2007-12-21	Mesilato de hidrogénio de 4-(4-trans-hidroxicicloexil) amino-2-fenil-7h-pirroloii2,3d] pirimidina e suas formas polimórficas
JP2024501202A (ja)	2024-01-11	四置換オレフィン化合物の塩形、結晶及びその製造方法
DE102007032613A1 (de)	2008-01-24	Spiraprilhydrochlorid und polymorphe Formen davon
CA2456233A1 (en)	2003-03-13	Paroxetine isethionate salt, process of preparation and use in the treatment of depression
KR20050019792A (ko)	2005-03-03	카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는조성물, 및(또는) 치료 방법